Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Altimmune, Inc. stock logo
ALT
Altimmune
$7.20
+1.7%
$9.35
$2.09
$14.84
$510.41M0.055.35 million shs2.31 million shs
American Tower Co. stock logo
AMT
American Tower
$172.90
-0.3%
$190.93
$154.58
$219.10
$80.63B0.672.42 million shs1.66 million shs
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$8.01
-1.0%
$8.82
$5.90
$11.27
$310.47M1.51157,354 shs73,690 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Altimmune, Inc. stock logo
ALT
Altimmune
-6.47%+0.57%-17.00%-23.71%+35.37%
American Tower Co. stock logo
AMT
American Tower
-0.49%+0.77%-11.36%-13.45%-14.07%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
+0.37%+3.45%-10.80%-5.16%-22.95%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Altimmune, Inc. stock logo
ALT
Altimmune
1.3496 of 5 stars
3.31.00.00.03.21.70.0
American Tower Co. stock logo
AMT
American Tower
4.9844 of 5 stars
4.45.02.53.12.72.51.9
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Altimmune, Inc. stock logo
ALT
Altimmune
2.67
Moderate Buy$15.00108.33% Upside
American Tower Co. stock logo
AMT
American Tower
2.82
Moderate Buy$217.3625.72% Upside
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
N/AN/AN/AN/A

Current Analyst Ratings

Latest VMD, ADR, AMT, and ALT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
American Tower Co. stock logo
AMT
American Tower
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$183.00 ➝ $196.00
4/8/2024
American Tower Co. stock logo
AMT
American Tower
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$205.00
4/1/2024
Altimmune, Inc. stock logo
ALT
Altimmune
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
3/28/2024
Altimmune, Inc. stock logo
ALT
Altimmune
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
3/5/2024
American Tower Co. stock logo
AMT
American Tower
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$224.00 ➝ $234.00
2/28/2024
American Tower Co. stock logo
AMT
American Tower
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$235.00 ➝ $228.00
2/28/2024
American Tower Co. stock logo
AMT
American Tower
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$236.00 ➝ $230.00
2/13/2024
Altimmune, Inc. stock logo
ALT
Altimmune
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Altimmune, Inc. stock logo
ALT
Altimmune
$430K1,187.00N/AN/A$2.75 per share2.62
American Tower Co. stock logo
AMT
American Tower
$11.14B7.24$9.84 per share17.58$23.30 per share7.42
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$183.01M1.70$0.83 per share9.67$2.96 per share2.71

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Altimmune, Inc. stock logo
ALT
Altimmune
-$88.45M-$1.65N/AN/AN/A-20,780.75%-44.77%-40.72%5/9/2024 (Estimated)
American Tower Co. stock logo
AMT
American Tower
$1.48B$3.1854.3716.751.3813.31%12.80%2.24%4/30/2024 (Confirmed)
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$10.24M$0.2630.81N/A5.60%9.59%7.09%5/7/2024 (Confirmed)

Latest VMD, ADR, AMT, and ALT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
N/AN/AN/AN/AN/AN/A
4/30/2024N/A
American Tower Co. stock logo
AMT
American Tower
$2.45N/A-$2.45N/AN/AN/A  
3/27/2024Q4 2023
Altimmune, Inc. stock logo
ALT
Altimmune
-$0.35-$0.33+$0.02-$0.12N/A$0.04 million
3/6/2024Q4 2023
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
N/A$0.09+$0.09$0.09N/A$50.74 million
2/27/202412/31/2023
American Tower Co. stock logo
AMT
American Tower
$2.10$0.94-$1.16$0.18$2.74 billion$2.79 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Altimmune, Inc. stock logo
ALT
Altimmune
N/AN/AN/AN/AN/A
American Tower Co. stock logo
AMT
American Tower
$6.483.75%+12.50%203.77%N/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
N/AN/AN/AN/AN/A

Latest VMD, ADR, AMT, and ALT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/14/2024
American Tower Co. stock logo
AMT
American Tower
quarterly$1.623.3%4/11/20244/12/20244/26/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Altimmune, Inc. stock logo
ALT
Altimmune
N/A
17.26
17.26
American Tower Co. stock logo
AMT
American Tower
3.29
0.69
0.69
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
0.05
1.19
1.05

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
78.05%
American Tower Co. stock logo
AMT
American Tower
92.69%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
74.24%

Insider Ownership

CompanyInsider Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
4.10%
American Tower Co. stock logo
AMT
American Tower
0.24%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
19.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Altimmune, Inc. stock logo
ALT
Altimmune
5970.89 million67.99 millionOptionable
American Tower Co. stock logo
AMT
American Tower
5,643466.35 million465.23 millionOptionable
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
99638.76 million31.32 millionNot Optionable

VMD, ADR, AMT, and ALT Headlines

SourceHeadline
Viemed Healthcare Announces Date and Time for Conference CallViemed Healthcare Announces Date and Time for Conference Call
globenewswire.com - April 23 at 9:00 AM
Viemed Healthcare: Long-Term Bull Remains Intact But Patience RequiredViemed Healthcare: Long-Term Bull Remains Intact But Patience Required
seekingalpha.com - April 17 at 8:27 AM
Triasima Portfolio Management inc. Trims Stock Position in Viemed Healthcare, Inc. (NASDAQ:VMD)Triasima Portfolio Management inc. Trims Stock Position in Viemed Healthcare, Inc. (NASDAQ:VMD)
marketbeat.com - April 14 at 11:11 AM
Analysts Offer Insights on Healthcare Companies: Silk Road Medical (SILK) and Viemed Healthcare (VMD)Analysts Offer Insights on Healthcare Companies: Silk Road Medical (SILK) and Viemed Healthcare (VMD)
markets.businessinsider.com - April 3 at 2:01 PM
Viemed gets controlling interest in Alabama HMEViemed gets controlling interest in Alabama HME
hmenews.com - April 2 at 2:00 PM
Viemed Announces Acquisition of Majority Interest in HomeMed, Forging Partnership With East Alabama HealthViemed Announces Acquisition of Majority Interest in HomeMed, Forging Partnership With East Alabama Health
globenewswire.com - April 2 at 9:00 AM
Viemed Healthcare, Inc. (VMD) Q4 2023 Earnings Call TranscriptViemed Healthcare, Inc. (VMD) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 9 at 4:47 PM
VMD stock wins price target raise at BeaconVMD stock wins price target raise at Beacon
cantechletter.com - March 7 at 4:59 PM
Viemed Healthcare Inc (VMD) Reports Record Financial Results for 2023Viemed Healthcare Inc (VMD) Reports Record Financial Results for 2023
finance.yahoo.com - March 7 at 3:41 PM
VMD Stock Earnings: Viemed Healthcare Misses EPS, Beats Revenue for Q4 2023VMD Stock Earnings: Viemed Healthcare Misses EPS, Beats Revenue for Q4 2023
msn.com - March 6 at 11:30 PM
Viemed Healthcare Announces Record 2023 Financial ResultsViemed Healthcare Announces Record 2023 Financial Results
globenewswire.com - March 6 at 5:00 PM
Heres what Wall Street expects from Viemed Healthcares earnings reportHere's what Wall Street expects from Viemed Healthcare's earnings report
markets.businessinsider.com - March 5 at 10:59 AM
Viemed Healthcare Inc.Viemed Healthcare Inc.
wsj.com - February 22 at 9:29 PM
Viemed Healthcare Announces Date and Time for Conference CallViemed Healthcare Announces Date and Time for Conference Call
globenewswire.com - February 20 at 4:30 PM
Investors in Viemed Healthcare (NASDAQ:VMD) have seen decent returns of 83% over the past five yearsInvestors in Viemed Healthcare (NASDAQ:VMD) have seen decent returns of 83% over the past five years
finance.yahoo.com - January 10 at 7:09 AM
Should You Hold Viemed Healthcare (VMD)?Should You Hold Viemed Healthcare (VMD)?
finance.yahoo.com - December 26 at 9:21 AM
Are Investors Undervaluing Viemed Healthcare, Inc. (NASDAQ:VMD) By 46%?Are Investors Undervaluing Viemed Healthcare, Inc. (NASDAQ:VMD) By 46%?
finance.yahoo.com - December 24 at 11:59 AM
Viemed Healthcare Inc Ordinary SharesViemed Healthcare Inc Ordinary Shares
morningstar.com - December 21 at 10:01 AM
Is Viemed Healthcare, Inc. (TSE:VMD) Trading At A 50% Discount?Is Viemed Healthcare, Inc. (TSE:VMD) Trading At A 50% Discount?
finance.yahoo.com - November 18 at 8:51 AM
Viemed Healthcare Inc Ordinary Shares VMDViemed Healthcare Inc Ordinary Shares VMD
morningstar.com - November 11 at 5:04 AM
Viemed Healthcare to Present at Stifel 2023 Healthcare ConferenceViemed Healthcare to Present at Stifel 2023 Healthcare Conference
finance.yahoo.com - November 7 at 9:40 AM
Viemed Healthcare, Inc.: Viemed Healthcare Announces Record Third Quarter 2023 Financial ResultsViemed Healthcare, Inc.: Viemed Healthcare Announces Record Third Quarter 2023 Financial Results
finanznachrichten.de - November 2 at 7:42 AM
Viemed Healthcare Announces Record Third Quarter 2023 Financial ResultsViemed Healthcare Announces Record Third Quarter 2023 Financial Results
finance.yahoo.com - November 1 at 6:12 PM
Viemed Healthcare Q3 2023 Earnings PreviewViemed Healthcare Q3 2023 Earnings Preview
msn.com - October 31 at 6:12 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Altimmune logo

Altimmune

NASDAQ:ALT
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.
American Tower logo

American Tower

NYSE:AMT
American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities.
Viemed Healthcare logo

Viemed Healthcare

NASDAQ:VMD
Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.